Comments
Loading...
Savara (NASDAQ:SVRA) Stock Quotes, Forecast and News Summary
Savara Stock (NASDAQ: SVRA) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Savara (SVRA) stock?
You can purchase shares of Savara (NASDAQ:SVRA) through any online brokerage.
Who are Savara (SVRA) competitors?
Other companies in Savara’s space includes: Celcuity (NASDAQ:CELC), Altimmune (NASDAQ:ALT), Pharming (NASDAQ:PHAR), Opthea (NASDAQ:OPT) and Neurogene (NASDAQ:NGNE).
What is the forecast, or price target, for Savara (SVRA) stock?
Savara has a consensus price target of $8.75.
What is the current price for Savara (SVRA)?
The stock price for Savara (NASDAQ: SVRA) is $2.95 last updated November 15, 2024 at 1:05 PM EST.
Does Savara (SVRA) pay a dividend?
There are no upcoming dividends for Savara.
When is Savara (NASDAQ:SVRA) reporting earnings?
Savara’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
Is Savara (SVRA) going to split?
There is no upcoming split for Savara.
What sector and industry does Savara (SVRA) operate in?
Savara is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.